Guest guest Posted December 11, 2006 Report Share Posted December 11, 2006 If I recall correctly off the top of my head, the ESPRIT trials began in the mid '90s. I can only conclude that there was no earth-shaking breakthrough from the use of IL-2 since we have not heard anything of note about it after a full ten years of study. Am I right in concluding that it inflates the number and percentage of cd4s, but they are in fact inert and inactive? I strongly suspect that if there were a noticeable advantage, in terms of either morbidity or mortality, associated with IL-2, it would have been widely reported by now. The silence on the subject leads me to think that nothing conclusive has been learned from the trial. --- Barrow wrote: > That's really all I can share right now, but there > will be more > coming soon. > > There is little interest in IL-2 at this point. > Perhaps if the > Esprit trial produces evidence of long term benefit, > that will be > reconsidered. I'll be very happy if some long term > benefit is shown > in a large population. To date, this has not been > observed. > > > > > ______________ > > Want to start your own business? > > Learn how on Yahoo! Small Business. > > http://smallbusiness.yahoo.com/r-index > > Barrow > pozbod@... > > > > test'; " > ________________________________________________________________________________\ ____ Want to start your own business? Learn how on Yahoo! Small Business. http://smallbusiness.yahoo.com/r-index Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.